Advertisement
Product › Details
Tedopi® cancer immunotherapy
Next higher product group | OSE-2101 (OSE Pharma) | |
Status | 2016-01-05 development p3 existent | |
Organisation | OSE Pharma S.A. | |
Today | OSE Immunotherapeutics S.A. | |
Group | OSE Immunotherapeutics (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cancer immunotherapy (immuno-oncology, I-O)
- [1] StromaCare. (2/13/24). "Press Release: StromaCare Appoints Georges Rawadi as CEO". Lyon....
- [2] Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres....
- [3] iOmx Therapeutics AG. (9/5/23). "Press Release: iOmx Therapeutics Appoints Dr. Nils Peter Debus as Chief Business Officer". Martinsried....
- [4] IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY....
- [5] Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen....
- [6] Aqemia SAS. (1/9/23). "Press Release: Servier and Aqemia Extend Collaboration on Undruggable Target in Immuno-Oncology". Paris....
- [7] Atara Biotherapeutics, Inc.. (12/20/22). "Press Release: Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty". Thousand Oaks, CA....
- [8] Atara Biotherapeutics, Inc.. (12/19/22). "Press Release: Atara Biotherapeutics’ Ebvallo (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD". Thousand Oaks, CA & Castres....
- [9] OSE Immunotherapeutics S.A.. (10/7/22). "Press Release: OSE Immunotherapeutics Appoints Nicolas Poirier as Chief Executive Officer". Nantes....
- [10] Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top